close

Enter

Log in using OpenID

Renal Stents Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026

embed
The global renal stents market size is expected to reach around USD 1 billion by 2026 end with a CAGR of around 40% during the forecast period, 2019-2026
Renal Stents Market Global Trends, Market Share, Industry Size, Growth,
Opportunities, and Market Forecast 2019 to 2026
The global renal stents market size is expected to reach around USD 1 billion by 2026
end with a CAGR of around 40% during the forecast period, 2019-2026
The fast-paced lifestyle of today is stressful which has led to some known health
disorders like high blood pressure, hypertension etc. Such disorders cause the
narrowing of the renal artery, which is the largest blood vessel that carries blood to
the kidneys thus causing blockage of blood flow and this phenomenon is called renal
stenosis. This is mainly caused by fibrous artery disease or atherosclerosis. The
treatment of stenting opens up the blockage restoring the blood flow. To carry out
this procedure, a renal stent is implanted by an invasive procedure that is minimal
and which balloon catheter and guide wire.
The rise of hypertension patients across the world have provided a healthy
environment for the growth of renal stents market globally. Along with that,
unhealthy and irregular eating habits, lack of exercise will also fuel the growth of
renal stents market across the world. The most common reason for people getting
renal stenosis in the old age group is atherosclerosis which is caused due to the
building up of plaque inside the arteries. Coronary artery disease, peripheral vascular
disease, stroke and chronic kidney disease are some of the complications that are
associated with renal artery stenosis. One of the remedies suggested by doctors is to
lower cholesterols levels of the body for which they provide prescribed medicine.
Angiotensin-Converting Enzyme (ACE) inhibitors and angiotensin II receptor blockers
are commonly used for lowering blood pressure thus treating renal artery stenosis.
Although the side effects associated with some renal artery stenosis medications and
also there is no proper treatment for renal artery stenosis causing due to
fibromuscular dysplasia are some of the drawbacks which could restrain the growth
of renal stents market.
Request a Sample Report @ https://www.futurewiseresearch.com/requestsample.aspx?id=216&page=requestsample
Insights on Global Renal Stents market:
1. By Region
• North America
• Europe
• Asia Pacific
• Latin America
• Rest of the World
North America and Europe hold a significant amount of global market share
dominating this market and it is expected to stay the same during the forecast
period. Asia Pacific is fast-growing and is currently the most opportunistic market
region for manufacturers due to a rise in the prevalence of renal artery stenosis.
Latin America and Rest of the World regions are yet to be explored in this market
and thus has a potential of strong growth opportunities and are expected to show a
consistent growth rate during the forecast period.
2. By Cause
• Atherosclerosis
• Fibromuscular Dysplasia
Around 90% of the total renal artery stenosis cases occur due to atherosclerosis. This
is because atherosclerosis is mainly found in the geriatric population which acquire a
larger share of the global patient pool and therefore will dominate this market
segment throughout the forecast period. Fibromuscular dysplasia is a rare kind of
renal artery stenosis and is commonly observed in the young age group and primarily
in women. The medications provided for fibromuscular dysplasia associated renal
stenosis have some side effects which will hamper the market growth resulting in a
slow rise during the forecast period.
3. By End User
• Hospitals
• Surgical centres
Hospitals have good infrastructure than some surgical centres which can perform the
implantation of renal stents with efficiency resulting in their dominance in this
market segment. It is expected that hospitals will be dominating the market during
the forecast period as well.
Purchase a Copy of this Premium Research Report & Ask For Discount:
https://www.futurewiseresearch.com/requestsample.aspx?id=216&page=askfordiscount
Competitive Landscape:
• Abbott Laboratories
• Boston Scientific Corp.
• Cook Medical
• Hexacath
FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global renal stents market by
region, by cause, by end-user
• To cater comprehensive information on factors impacting market growth (drivers,
restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)—North America,
Europe, Asia Pacific, Latin America, and Rest of the World
• To record evaluate and competitive landscape mapping- product launches,
technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and
core competencies
Table of Contents
1.1. Introduction
1.1.1.1. Scope and Objective
1.1.1.2. Assumptions and Acronyms
1.1.1.3. Forecast Factors
1.1.1.4. Research Methodology
1.2. Executive Summary
1.2.1.1. Industry Cluster Analysis
1.2.1.2. Competition Matrix
1.2.1.3. Strategies Recommendations
1.3. Market Definition
1.3.1.1. Report Scope (Inclusions & Exclusions)
1.3.1.2. Market Segmentation
1.4. Global Renal Stents Market Overview
1.4.1.1. Global Renal Stents Market Revenue (USD Mn)
1.5. Key Inclusions
1.5.1.1. Porter’s Five Force analysis
1.5.1.2. Market Dynamics
1.5.1.3. Industry Trends
1.5.1.4. Regulatory Guidelines
1.5.1.5. Opportunities in Renal Stents
1.6. Competition Dynamics
1.6.1.1. Company Share Analysis (2018)
1.6.1.2. Top 10 Product Pricing by Region
1.7. Global Renal Stents Market Revenue (USD Mn), 2018-2026 by Stent Type
1.7.1.1. Key Market Findings
1.7.1.2. Long Term ROI Segments
1.7.1.3. Revenue Opportunity Influencing Factors
1.7.1.4. Market Revenue (USD Mn) Assessment and Forecast by Stent
Type, 2018-2026
1.7.1.4.1.1.
Double Pigtail Renal Stents
1.7.1.4.1.2.
Open End Renal Stents
1.7.1.4.1.3.
Closed End Renal Stents
1.8. Global Renal Stents Market Revenue (USD Mn), 2018-2026 by End User
1.8.1.1. Key Market Findings
1.8.1.2. Long Term ROI Segments
1.8.1.3. Revenue Opportunity Influencing Factors
1.8.1.4. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.8.1.4.1.1.
Hospital
1.8.1.4.1.2.
Outpatient Centres
1.8.1.4.1.3.
Specialty Clinics
1.9. Global Renal Stents Market Revenue (USD Mn), 2018-2026 by Region
1.9.1.1. Key Market Findings
1.9.1.2. Long Term ROI Segments
1.9.1.3. Revenue Opportunity Influencing Factors
1.9.1.4. Market Revenue (USD Mn) Assessment and Forecast by
Region,2026
1.9.1.4.1.1.
North America
1.9.1.4.1.2.
Latin America
1.9.1.4.1.3.
Europe
1.9.1.4.1.4.
Asia Pacific
1.9.1.4.1.5.
Rest of world
1.10.
North America Renal Stents Market Revenue (US$ Mn), 2018-2026
1.10.1.1. Key Market Findings
1.10.1.2. Long Term ROI Segments
1.10.1.3. Revenue Opportunity Influencing Factors
1.10.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
1.10.1.4.1.1.
US
1.10.1.4.1.2.
Canada
1.10.1.5. Market Revenue (USD Mn) Assessment and Forecast by Stent
Type, 2018-2026
1.10.1.5.1.1.
Double Pigtail Renal Stents
1.10.1.5.1.2.
Open End Renal Stents
1.10.1.5.1.3.
Closed End Renal Stents
1.10.1.6. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.10.1.6.1.1.
Hospital
1.10.1.6.1.2.
Outpatient Centres
1.10.1.6.1.3.
Specialty Clinics
1.11.
Latin America Renal Stents Market Revenue (US$ Mn), 2018-2026
1.11.1.1. Key Market Findings
1.11.1.2. Long Term ROI Segments
1.11.1.3. Revenue Opportunity Influencing Factors
1.11.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
1.11.1.4.1.1.
Brazil
1.11.1.4.1.2.
Mexico
1.11.1.4.1.3.
Argentina
1.11.1.4.1.4.
Rest of Latin America
1.11.1.5. Market Revenue (USD Mn) Assessment and Forecast by Stent
Type, 2018-2026
1.11.1.5.1.1.
Double Pigtail Renal Stents
1.11.1.5.1.2.
Open End Renal Stents
1.11.1.5.1.3.
Closed End Renal Stents
1.11.1.6. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.11.1.6.1.1.
Hospital
1.11.1.6.1.2.
Outpatient Centres
1.11.1.6.1.3.
Specialty Clinics
1.12.
Europe America Renal Stents Market Revenue (US$ Mn), 2018-2026
1.12.1.1. Key Market Findings
1.12.1.2. Long Term ROI Segments
1.12.1.3. Revenue Opportunity Influencing Factors
1.12.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
1.12.1.4.1.1.
Germany
1.12.1.4.1.2.
France
1.12.1.4.1.3.
Spain
1.12.1.4.1.4.
UK
1.12.1.4.1.5.
Russia
1.12.1.4.1.6.
Poland
1.12.1.4.1.7.
Rest of Europe
1.12.1.5. Market Revenue (USD Mn) Assessment and Forecast by Stent
Type, 2018-2026
1.12.1.5.1.1.
Double Pigtail Renal Stents
1.12.1.5.1.2.
Open End Renal Stents
1.12.1.5.1.3.
Closed End Renal Stents
1.12.1.6. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.12.1.6.1.1.
Hospital
1.12.1.6.1.2.
Outpatient Centres
1.12.1.6.1.3.
Specialty Clinics
1.13.
Asia Pacific America Renal Stents Market Revenue (US$ Mn), 20182026
1.13.1.1. Key Market Findings
1.13.1.2. Long Term ROI Segments
1.13.1.3. Revenue Opportunity Influencing Factors
1.13.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
1.13.1.4.1.1.
Emerging Asia
1.13.1.4.1.1.1.1. China
1.13.1.4.1.1.1.2. India
1.13.1.4.1.1.1.3. ASEAN-5
1.13.1.4.1.1.1.4. Rest of Emerging Asia
1.13.1.4.1.2.
Japan
1.13.1.5. Market Revenue (USD Mn) Assessment and Forecast by Stent
Type, 2018-2026
1.13.1.5.1.1.
Double Pigtail Renal Stents
1.13.1.5.1.2.
Open End Renal Stents
1.13.1.5.1.3.
Closed End Renal Stents
1.13.1.6. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.13.1.6.1.1.
Hospital
1.13.1.6.1.2.
Outpatient Centres
1.13.1.6.1.3.
Specialty Clinics
1.14.
Rest of World America Renal Stents Market Revenue (US$ Mn), 20182026
1.14.1.1. Key Market Findings
1.14.1.2. Long Term ROI Segments
1.14.1.3. Revenue Opportunity Influencing Factors
1.14.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
1.14.1.4.1.1.
Middle East
1.14.1.4.1.2.
South Africa
1.14.1.4.1.3.
North Africa
1.14.1.4.1.4.
Rest of World
1.14.1.5. Market Revenue (USD Mn) Assessment and Forecast by Stent
Type, 2018-2026
1.14.1.5.1.1.
Double Pigtail Renal Stents
1.14.1.5.1.2.
Open End Renal Stents
1.14.1.5.1.3.
Closed End Renal Stents
1.14.1.6. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.14.1.6.1.1.
Hospital
1.14.1.6.1.2.
Outpatient Centres
1.14.1.6.1.3.
Specialty Clinics
1.15.
Company Profiles
1.15.1.1. Competition Landscape
1.15.1.2. Global Company Share (USD Mn) Overview, 2018
1.15.1.3. Company Profiles
1.15.1.3.1.1.
Boston Scientific Corporation
1.15.1.3.1.1.1.1. Corporate Overview
1.15.1.3.1.1.1.2. Financial Performance
1.15.1.3.1.1.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.1.1.4. Company Strategy & Channel Management
1.15.1.3.1.2.
Opti-Med
1.15.1.3.1.2.1.1. Corporate Overview
1.15.1.3.1.2.1.2. Financial Performance
1.15.1.3.1.2.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.2.1.4. Company Strategy & Channel Management
1.15.1.3.1.3.
B. Braun Melsungen AG
1.15.1.3.1.3.1.1. Corporate Overview
1.15.1.3.1.3.1.2. Financial Performance
1.15.1.3.1.3.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.3.1.4. Company Strategy & Channel Management
1.15.1.3.1.4.
Blue Neem Medical Devices Pvt Ltd
1.15.1.3.1.4.1.1. Corporate Overview
1.15.1.3.1.4.1.2. Financial Performance
1.15.1.3.1.4.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.4.1.4. Company Strategy & Channel Management
1.15.1.3.1.5.
Bio-enterprise
1.15.1.3.1.5.1.1. Corporate Overview
1.15.1.3.1.5.1.2. Financial Performance
1.15.1.3.1.5.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.5.1.4. Company Strategy & Channel Management
1.15.1.3.1.6.
Palex Medical
1.15.1.3.1.6.1.1. Corporate Overview
1.15.1.3.1.6.1.2. Financial Performance
1.15.1.3.1.6.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.6.1.4. Company Strategy & Channel Management
1.15.1.3.1.7.
Cook Medical
1.15.1.3.1.7.1.1. Corporate Overview
1.15.1.3.1.7.1.2. Financial Performance
1.15.1.3.1.7.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.7.1.4. Company Strategy & Channel Management
1.16.
Research Sources & Primary Verbatim
Inquire further details about this report at: [email protected]
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and
customised solutions for our clients. Through in-depth market insights and
consultancy, we present our clients with the tools they need to be at the forefront of
their industry – a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
1/--pages
Report inappropriate content